San Diego, CA (June, 1 - 2, 2016)
The discovery of penicillin in 1928 was a major success and antibiotics have been used to treat a large number of patients with infectious disease. Over the almost 100 years since Fleming's discovery of penicillin, the bugs have developed resistance to antibiotics and continue to adapt at an disturbing rate to new and emerging therapies. The increase and spread of antibiotic-resistance and the reduced investment by the pharmaceutical industry have given us an unsettling glimpse of a post-antibiotic era. Ultimately, it is the goal of the scientific community, and certainly that of the attendees, to forestall that event and to prevent the serious consequences that would come inevitably from it.
The 2nd Bugs & Drugs: Antibacterial Drug Discovery conference is designed to bring leaders from academic, pharmaceutical and biotech communities, scientists and clinicians together for 2 days to discuss the development and discovery of new antibiotics, new diagnostics, new targets and non-traditional approaches to tackling multi-drug resistance.
Více: https://www.gtcbio.com/conferences/bugs-drugs-antibacterial-discovery-
Gate2Biotech - Biotechnologický portál - Vše o biotechnologiích na jednom místě.
ISSN 1802-2685
Tvorba webových stránek: CREOS CZ
© 2006 - 2024 Jihočeská agentura pro podporu inovačního podnikání o.p.s.
Zajímavé články s biotechnologickým obsahem:
Brigády pro studenty - Nabídky zajímavých brigád pro studenty
Věda technika výzkum - Přehled zpráv z vědy techniky a výzkumu.
Vědci objevili antibakteriální umbrella proteiny u půdních bakterií
Léčba melanomu s mRNA snižuje riziko úmrtí o polovinu